网站地图
Home
About Us
Science & Pipeline
partnering
News
-
-
Shimai Pharma Presents DNV3 (LAG-3 Antibody) Combination Therapy Results for Melanoma at ASCO 2025 Annual Meeting Shimai Pharma Presents SMET12 (EGFR×CD3 Bispecific Antibody) Combination Therapy Results for Advanced NSCLC at ASCO 2025 Annual Meeting International Endorsement, Global Leadership | GPC3×CD3 Bispecific Antibody CMD011 Receives FDA IND Clearance
-
Join Us